(2023)
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
5
(2022)
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease.
CELL REPORTS.
40,
12
(2022)
Multi-Omics-Based Autophagy-Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology.
ADVANCED SCIENCE.
9,
23
(2022)
Application of QPLEXTM biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition.
EXPERIMENTAL AND MOLECULAR MEDICINE.
54,
1
(2021)
The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit.
EXPERIMENTAL AND MOLECULAR MEDICINE.
53,
6
(2021)
A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids.
NATURE COMMUNICATIONS.
12,
1
(2021)
Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition.
ALZHEIMERS RESEARCH & THERAPY.
13,
1
학술회의논문
(2023)
Functional brain organoid-based precision medicine platform for neurodegenerative diseases.
2023년 제15회 대한퇴행성신경질환학회 학술대회.
대한민국
(2023)
Unveiling the Quantum Secrets of the Brain: Integrating Brain Organoids and Quantum Biology for Future Neurodegenerative Disease Research.
World Innovation Summit for Neurodegenerative Diseases Opportunities and Challenges in Medicine: WISDOM.
대한민국
(2023)
Brain organoid-based bioconvergence researches for precision medicine.
2023 오가노이드학회 춘계학술대회.
대한민국
